Read articles from Global

July 08, 2026 by filtermag.org

Quitting smoking is rarely an individual journey. The benefits extend far beyond the smoker, improving the health, relationships and quality of life of partners, children and loved ones. Smoke-free alternatives can help create healthier homes, more shared time and fewer harms from secondhand smoke. Harm reduction is not just about saving one life — it can improve the wellbeing of entire families.

July 07, 2026 by gfn.tv

Drug policy and tobacco policy face the same core challenge: reducing harm in the real world, not demanding perfect behaviour. Whether the issue is illicit drugs, smoking or nicotine use, prohibition and stigma often push people further from support and safer choices. Harm reduction offers a shared solution by prioritising evidence, dignity and practical routes to lower risk. Public health should meet people where they are — and help them move towards safer outcomes.

July 02, 2026 by johnmenadue.com

Australia’s vape and tobacco policy shows the cost of making safer products harder to access than cigarettes. Legal vapes are restricted through pharmacies, while combustible tobacco remains widely available, leaving smokers with fewer practical routes away from the most harmful option. A successful policy would regulate nicotine by risk, protect young people and keep lower-risk alternatives in legal, accountable channels. Harm reduction should replace a system that is failing both smokers and public health.

July 02, 2026 by youtube.com

The real costs of prohibition are paid by consumers, communities and public health systems. When safer nicotine products are banned or heavily restricted, demand does not disappear — it shifts towards illicit markets, unsafe supply chains and continued cigarette use. These policies can increase stigma, reduce trust and make harm reduction harder to access. Evidence-based regulation should reduce risk in the real world, not create new harms in pursuit of perfect control.

July 02, 2026 by gfn.tv

The real costs of prohibition are paid by consumers, communities and public health systems. When safer nicotine products are banned or heavily restricted, demand does not disappear — it shifts towards illicit markets, unsafe supply chains and continued cigarette use. These policies can increase stigma, reduce trust and make harm reduction harder to access. Evidence-based regulation should reduce risk in the real world, not create new harms in pursuit of perfect control.

June 30, 2026 by gfn.tv

Prohibition carries economic costs that go far beyond enforcement. When safer nicotine products are banned or heavily restricted, legal businesses lose ground, tax revenue declines and illicit markets gain power. Consumers are left with fewer regulated options while criminal networks benefit from demand that never disappeared. Harm reduction is not only a health strategy — it is also a way to keep safer products within accountable, legal markets.

June 26, 2026 by gfn.tv

If most global vaping now sits outside legal markets, prohibition is not controlling nicotine use — it is losing control of it. Illicit supply leaves consumers with weaker safeguards, less product transparency and fewer age controls, while cigarettes often remain legally available. The lesson is straightforward: demand does not disappear when safer products are banned or overrestricted. Harm reduction needs regulated access, not black-market dependence.

June 26, 2026 by substack.com

Smokers deserve better than advice that treats vaping as no different from cigarettes. While no nicotine product is risk-free, public health guidance should clearly distinguish between combustible tobacco and smoke-free alternatives that reduce exposure to toxicants. When trusted institutions blur that distinction, smokers may be discouraged from switching to lower-risk options. Accurate risk communication is not a concession to nicotine — it is a necessary part of reducing smoking-related harm.

June 26, 2026 by blogspot.com

Poorly designed e-cigarette studies can do real damage when weak methods are turned into strong public health claims. If research fails to account for smoking history, product use patterns or the difference between association and causation, it risks misleading policymakers and the public. Vaping should be scrutinised, but the evidence must be held to serious scientific standards. Harm reduction policy should be guided by robust data, not studies that confuse risk rather than clarify it.

June 25, 2026 by gfn.tv

Prohibition carries health, wellbeing and ethical costs that are often overlooked. When safer nicotine products are restricted, people may be pushed towards cigarettes, illicit markets or unsafe supply chains. Harm reduction offers a more humane approach by reducing risk without demanding perfect abstinence. Public health should protect people in the real world, not punish them for using nicotine.